{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:39:41Z","timestamp":1784356781617,"version":"3.55.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clineuro.2025.109205","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T07:58:55Z","timestamp":1761379135000},"page":"109205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Medication-overuse headache: Bridging therapies for detoxification"],"prefix":"10.1016","volume":"259","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1016-5207","authenticated-orcid":false,"given":"Benjamin R.","family":"Wakerley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prut","family":"Koonalintip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.clineuro.2025.109205_bib1","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/life14091146","article-title":"Medication-Overuse Headache: Update on Management","volume":"14","author":"Koonalintip","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.clineuro.2025.109205_bib2","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition 1 38 Cephalalgia2018 Jan, 1211.","DOI":"10.1177\/0333102417738202"},{"issue":"7","key":"10.1016\/j.clineuro.2025.109205_bib3","first-page":"1","article-title":"Headache classification committee of the international headache society","volume":"8","author":"Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain","year":"1988","journal-title":"Cephalalgia Int J. Headache"},{"issue":"10","key":"10.1016\/j.clineuro.2025.109205_bib4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1526-4610.1990.hed3010634.x","article-title":"Drug induced refractory headache--clinical features and management","volume":"30","author":"Mathew","year":"1990","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.clineuro.2025.109205_bib5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0333102413512033","article-title":"Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review","volume":"34","author":"Westergaard","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.clineuro.2025.109205_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s10194-015-0561-1","article-title":"Clinical and demographical characteristics of patients with medication overuse headache in Argentina and Chile: analysis of the Latin American section of COMOESTAS project","volume":"16","author":"Shand","year":"2015","journal-title":"J. Headache Pain."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/ene.12794","article-title":"Psychopathological comorbidities in medication-overuse headache: a multicentre clinical study","volume":"23","author":"Sarchielli","year":"2016","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2025.109205_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrneurol.2016.124","article-title":"Medication-overuse headache: risk factors, pathophysiology and management","volume":"12","author":"Diener","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.clineuro.2025.109205_bib9","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1177\/0333102417728244","article-title":"A systematic review and critical appraisal of gene polymorphism association studies in medication-overuse headache","volume":"38","author":"Cargnin","year":"2018","journal-title":"Cephalalgia"},{"issue":"9","key":"10.1016\/j.clineuro.2025.109205_bib10","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jamaneurol.2020.1179","article-title":"Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial","volume":"77","author":"Carlsen","year":"2020","journal-title":"JAMA Neurol."},{"issue":"10","key":"10.1016\/j.clineuro.2025.109205_bib11","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1468-2982.2006.01190.x","article-title":"Discontinuation of Medication Overuse in Headache Patients: Recovery of Therapeutic Responsiveness","volume":"26","author":"Zeeberg","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1016\/j.clineuro.2025.109205_bib12","article-title":"Medication-overuse headache-a review of different treatment strategies","volume":"4","author":"Krymchantowski","year":"2023","journal-title":"Front Pain. Res Lausanne Switz."},{"issue":"6","key":"10.1016\/j.clineuro.2025.109205_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jpain.2016.12.005","article-title":"The effectiveness of treatments for patients with medication overuse headache: a systematic review and meta-analysis","volume":"18","author":"De Goffau","year":"2017","journal-title":"J. Pain."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s10194-025-01982-9","article-title":"Network meta-analysis comparing efficacy of different strategies on medication-overuse headache","volume":"26","author":"Koonalintip","year":"2025","journal-title":"J. Headache Pain."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109205_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/0333102417737779","article-title":"Complete detoxification is the most effective treatment of medication-overuse headache: a randomized controlled open-label trial","volume":"38","author":"Carlsen","year":"2018","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1129-2377-14-10","article-title":"Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial","volume":"14","author":"Rossi","year":"2013","journal-title":"J. Headache Pain."},{"issue":"5","key":"10.1016\/j.clineuro.2025.109205_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jamcollsurg.2018.08.183","article-title":"American College of Surgeons\u2019 guidelines for the perioperative management of antithrombotic medication","volume":"227","author":"Hornor","year":"2018","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.clineuro.2025.109205_bib18","unstructured":"Katsarava Z., Fritsche G., Muessig M., Diener H.C., Limmroth V. CME Clinical features of withdrawal headache following overuse of triptans and other headache drugs."},{"issue":"5","key":"10.1016\/j.clineuro.2025.109205_bib19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1526-4610.2008.01097.x","article-title":"The discovery and development of the triptans, a major therapeutic breakthrough","volume":"48","author":"Humphrey","year":"2008","journal-title":"Headache"},{"issue":"8","key":"10.1016\/j.clineuro.2025.109205_bib20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1468-2982.2008.01578.x","article-title":"History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward","volume":"28","author":"Tfelt-Hansen","year":"2008","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.clineuro.2025.109205_bib21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1526-4610.1963.hed0204214.x","article-title":"Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases","volume":"2","author":"Horton","year":"1963","journal-title":"Headache J. Head. Face Pain."},{"issue":"9","key":"10.1016\/j.clineuro.2025.109205_bib22","first-page":"153","article-title":"Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects","volume":"26","author":"Peters","year":"1951","journal-title":"Proc. Staff Meet. Mayo Clin."},{"issue":"Pt 1","key":"10.1016\/j.clineuro.2025.109205_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/123.1.9","article-title":"Ergotamine in the acute treatment of migraine: a review and European consensus","volume":"123","author":"Tfelt-Hansen","year":"2000","journal-title":"Brain J. Neurol."},{"issue":"4","key":"10.1016\/j.clineuro.2025.109205_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0361-1124(78)80310-4","article-title":"Ergotaminism","volume":"7","author":"Harrison","year":"1978","journal-title":"JACEP"},{"issue":"3","key":"10.1016\/j.clineuro.2025.109205_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF02082717","article-title":"Retroperitoneal fibrosis after long-term daily use of ergotamine","volume":"18","author":"Damstrup","year":"1986","journal-title":"Int Urol. Nephrol."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0733-8619(05)70304-2","article-title":"Opioids in headache treatment","volume":"15","author":"Ziegler","year":"1997","journal-title":"Is. there a role? Neurol. Clin."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1468-2982.1994.1401005.x","article-title":"Opiate and opioid use in patients with refractory headache","volume":"14","author":"Ziegler","year":"1994","journal-title":"Cephalalgia Int J. Headache"},{"key":"10.1016\/j.clineuro.2025.109205_bib28","unstructured":"Shah M., Huecker M.R. Opioid Withdrawal. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Feb 3]. Available from: \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK526012\/\u3009."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109205_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamapsychiatry.2020.3554","article-title":"Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders: a multivariable mendelian randomization analysis","volume":"78","author":"Rosoff","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"12","key":"10.1016\/j.clineuro.2025.109205_bib30","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jama.1955.02950290026009","article-title":"Drug-induced mood changes in man: 1. observations on healthy subjects, chronically ill patients, and \u2018postaddicts","volume":"157","author":"Lasagna","year":"1955","journal-title":"J. Am. Med Assoc."},{"issue":"11","key":"10.1016\/j.clineuro.2025.109205_bib31","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1360-0443.1994.tb03745.x","article-title":"Opiate withdrawal","volume":"89","author":"Farrell","year":"1994","journal-title":"Addict. Abingdon Engl."},{"issue":"12","key":"10.1016\/j.clineuro.2025.109205_bib32","first-page":"CD009281","article-title":"Caffeine as an analgesic adjuvant for acute pain in adults","volume":"2014","author":"Derry","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.clineuro.2025.109205_bib33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40122-024-00581-x","article-title":"The role of the combination paracetamol\/caffeine in treatment of acute migraine pain: a narrative review","volume":"13","author":"Barbanti","year":"2024","journal-title":"Pain. Ther."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s10194-017-0806-2","article-title":"Caffeine in the management of patients with headache","volume":"18","author":"Lipton","year":"2017","journal-title":"J. Headache Pain."},{"issue":"Pt 1","key":"10.1016\/j.clineuro.2025.109205_bib35","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.fct.2017.04.002","article-title":"Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children","volume":"109","author":"Wikoff","year":"2017","journal-title":"Food Chem. Toxicol. Int J. Publ. Br. Ind. Biol. Res Assoc."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109205_bib36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0091-3057(88)90180-3","article-title":"Reinforcing properties of caffeine: studies in humans and laboratory animals","volume":"29","author":"Griffiths","year":"1988","journal-title":"Pharm. Biochem Behav."},{"issue":"16","key":"10.1016\/j.clineuro.2025.109205_bib37","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJM199210153271601","article-title":"Withdrawal syndrome after the double-blind cessation of caffeine consumption","volume":"327","author":"Silverman","year":"1992","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.clineuro.2025.109205_bib38","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpba.2006.04.007","article-title":"Determination of paracetamol: Historical evolution","volume":"42","author":"Bosch","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.clineuro.2025.109205_bib39","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/clpt.1992.202","article-title":"Psychoactivity and abuse potential of sumatriptan","volume":"52","author":"Sullivan","year":"1992","journal-title":"Clin. Pharm. Ther."},{"issue":"5","key":"10.1016\/j.clineuro.2025.109205_bib40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jpainsymman.2005.10.006","article-title":"A Comparison of the Abuse Liability of Tramadol, NSAIDs, and Hydrocodone in Patients with Chronic Pain","volume":"31","author":"Adams","year":"2006","journal-title":"J. Pain. Symptom Manag."},{"issue":"9","key":"10.1016\/j.clineuro.2025.109205_bib41","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/scan\/nsw057","article-title":"From painkiller to empathy killer: acetaminophen (paracetamol) reduces empathy for pain","volume":"11","author":"Mischkowski","year":"2016","journal-title":"Soc. Cogn. Affect Neurosci."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45267-0","article-title":"A pill as a quick solution: association between painkiller intake, empathy, and prosocial behavior","volume":"13","author":"Banwinkler","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.clineuro.2025.109205_bib43","first-page":"351","article-title":"Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action","volume":"8","author":"Ayoub","year":"2021","journal-title":"Temp. Austin Tex."},{"issue":"9","key":"10.1016\/j.clineuro.2025.109205_bib44","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0269881117711708","article-title":"Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy","volume":"31","author":"Kopschina Feltes","year":"2017","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0031-9384(95)02036-5","article-title":"Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans","volume":"59","author":"Murphy","year":"1996","journal-title":"Physiol. Behav."},{"issue":"11","key":"10.1016\/j.clineuro.2025.109205_bib46","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.clinthera.2006.11.018","article-title":"Effects of ibuprofen on sleep quality as measured using polysomnography and subjective measures in healthy adults","volume":"28","author":"Gengo","year":"2006","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00004714-199502000-00012","article-title":"Recurrent depression after sumatriptan administration for treatment of migraine","volume":"15","author":"LaPorta","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.clineuro.2025.109205_bib48","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1468-2982.2000.00111.x","article-title":"Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness?","volume":"20","author":"Millson","year":"2000","journal-title":"Cephalalgia Int J. Headache"},{"issue":"4","key":"10.1016\/j.clineuro.2025.109205_bib49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1468-2982.2002.00344.x","article-title":"CNS effects of sumatriptan and rizatriptan in healthy female volunteers","volume":"22","author":"van der Post","year":"2002","journal-title":"Cephalalgia Int J. Headache"},{"issue":"5","key":"10.1016\/j.clineuro.2025.109205_bib50","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s13760-021-01758-3","article-title":"FRAMES protocol versus simple advice for medication-overuse headache: a prospective, randomized, controlled clinical trial","volume":"121","author":"Moraes Alves","year":"2021","journal-title":"Acta Neurol. Belg."},{"issue":"5","key":"10.1016\/j.clineuro.2025.109205_bib51","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/ene.15256","article-title":"Behavioural intervention in medication overuse headache: A concealed double-blind randomized controlled trial","volume":"29","author":"Pijpers","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2025.109205_bib52","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/jnnp-2014-308548","article-title":"Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial","volume":"86","author":"Kristoffersen","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.clineuro.2025.109205_bib53","first-page":"S202","article-title":"Evidence-based understanding of medication-overuse headache: clinical implications","volume":"46","author":"Dodick","year":"2006","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.clineuro.2025.109205_bib54","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1212\/WNL.36.7.995","article-title":"Repetitive intravenous dihydroergotamine as therapy for intractable migraine","volume":"36","author":"Raskin","year":"1986","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.clineuro.2025.109205_bib55","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1526-4610.1986.hed2604168.x","article-title":"A controlled study of dihydroergotamine in the treatment of acute migraine headache","volume":"26","author":"Callaham","year":"1986","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.clineuro.2025.109205_bib56","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1526-4610.1987.hed2703130.x","article-title":"Amelioration of ergotamine withdrawal symptoms with naproxen","volume":"27","author":"Mathew","year":"1987","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.clineuro.2025.109205_bib57","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1526-4610.1991.hed3104205.x","article-title":"Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache","volume":"31","author":"Diener","year":"1991","journal-title":"Headache"},{"issue":"9","key":"10.1016\/j.clineuro.2025.109205_bib58","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1526-4610.1998.3809687.x","article-title":"Daily sumatriptan for detoxification from rebound","volume":"38","author":"Drucker","year":"1998","journal-title":"Headache"},{"issue":"10","key":"10.1016\/j.clineuro.2025.109205_bib59","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1526-4610.1993.hed3310541.x","article-title":"Intravenous Acetylsalicylic Acid Inhibits Central Trigeminal Neurons in the Dorsal Horn of the Upper Cervical Spinal Cord in the Cat","volume":"33","author":"Kaube","year":"1993","journal-title":"Headache J. Head. Face Pain."},{"issue":"6","key":"10.1016\/j.clineuro.2025.109205_bib60","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1468-2982.1999.019006581.x","volume":"19","author":"Diener","year":"1999","journal-title":"Cephalalgia Int J. Headache"},{"issue":"12","key":"10.1016\/j.clineuro.2025.109205_bib61","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1212\/WNL.0b013e3181f39a11","article-title":"Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache","volume":"75","author":"Weatherall","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib62","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/head.12487","article-title":"Celecoxib vs Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind clinical trial","volume":"55","author":"Taghdiri","year":"2015","journal-title":"Headache J. Head. Face Pain."},{"issue":"4","key":"10.1016\/j.clineuro.2025.109205_bib63","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11916-012-0273-z","article-title":"The role of corticosteroids in the treatment of pain in cancer patients","volume":"16","author":"Leppert","year":"2012","journal-title":"Curr. Pain. Headache Rep."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109205_bib64","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1526-4610.1986.hed2602074.x","article-title":"Emergency treatment of intractable migraine","volume":"26","author":"Gallagher","year":"1986","journal-title":"Headache J. Head. Face Pain."},{"issue":"7657","key":"10.1016\/j.clineuro.2025.109205_bib65","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/bmj.39566.806725.BE","article-title":"Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrence","volume":"336","author":"Colman","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.clineuro.2025.109205_bib66","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/ene.14268","article-title":"European Academy of Neurology guideline on the management of medication-overuse headache","volume":"27","author":"Diener","year":"2020","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109205_bib67","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1468-2982.2000.00028.x","article-title":"Prednisone as initial treatment of analgesic-induced daily headache","volume":"20","author":"Krymchantowski","year":"2000","journal-title":"Cephalalgia Int J. Headache"},{"issue":"3","key":"10.1016\/j.clineuro.2025.109205_bib68","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/0333102412462638","article-title":"Prednisone for the treatment of withdrawal headache in patients with medication overuse headache: a randomized, double-blind, placebo-controlled study","volume":"33","author":"Rabe","year":"2013","journal-title":"Cephalalgia Int J. Headache"},{"issue":"10","key":"10.1016\/j.clineuro.2025.109205_bib69","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1046\/j.1468-2982.2003.00648.x","article-title":"Out-patient detoxification in CM: comparison of strategies","volume":"23","author":"Krymchantowski","year":"2003","journal-title":"Cephalalgia Int J. Headache"},{"issue":"4","key":"10.1016\/j.clineuro.2025.109205_bib70","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s10194-005-0225-7","article-title":"Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable CM and probable medication overuse headache","volume":"6","author":"Trucco","year":"2005","journal-title":"J. Headache Pain."},{"issue":"9","key":"10.1016\/j.clineuro.2025.109205_bib71","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1468-2982.2006.01175.x","article-title":"Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs","volume":"26","author":"Rossi","year":"2006","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.clineuro.2025.109205_bib72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1468-2982.2007.01488.x","article-title":"Prednisone vs. placebo in withdrawal therapy following medication overuse headache","volume":"28","author":"Pageler","year":"2008","journal-title":"Cephalalgia Int J. Headache"},{"issue":"11","key":"10.1016\/j.clineuro.2025.109205_bib73","first-page":"2025","article-title":"Methylprednisolone plus diazepam i.v. as bridge therapy for medication overuse headache","volume":"38","author":"Paolucci","year":"2017","journal-title":"Neurol. Sci. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s10194-017-0763-9","article-title":"Treatment of withdrawal headache in patients with medication overuse headache: a pilot study","volume":"18","author":"Cevoli","year":"2017","journal-title":"J. Headache Pain."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109205_bib75","first-page":"499","article-title":"Drug withdrawal along with bridge therapy with methylprednisolone and\/or diazepam for treatment of medication overuse headache: a preliminary report from the wash-out study","volume":"41","author":"Vernieri","year":"2020","journal-title":"Neurol. Sci. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109205_bib76","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/head.14667","article-title":"Effect of prednisolone for the treatment of medication-overuse headache: A 3-month result from a multicenter registry for Load and management of mEdicAtion overuSE headache (release) study","volume":"64","author":"Lee","year":"2024","journal-title":"Headache J. Head. Face Pain."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib77","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/01.wnl.0000263652.46222.e8","article-title":"Prednisolone does not reduce withdrawal headache: a randomized, double-blind study","volume":"69","author":"B\u00f8e","year":"2007","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.clineuro.2025.109205_bib78","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jpain.2016.12.005","article-title":"The effectiveness of treatments for patients with medication overuse headache: a systematic review and meta-analysis","volume":"18","author":"De Goffau","year":"2017","journal-title":"J. Pain."},{"issue":"10","key":"10.1016\/j.clineuro.2025.109205_bib79","first-page":"1264","article-title":"Is prednisone still a reasonable option in the treatment of withdrawal headache in patients with CM and medication overuse","volume":"62","author":"Kaltseis","year":"2022","journal-title":"Headache age CGRP antibodies? A Narrat. Rev. Headache"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib80","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00000441-198701000-00008","article-title":"The management of nausea and vomiting in clinical oncology","volume":"293","author":"Craig","year":"1987","journal-title":"Am. J. Med Sci."},{"issue":"7","key":"10.1016\/j.clineuro.2025.109205_bib81","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00900958","article-title":"Lignocaine and headache: An electrophysiological study in the cat with supporting clinical observations in man","volume":"241","author":"Kaube","year":"1994","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.clineuro.2025.109205_bib82","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1468-2982.1991.1106245.x","article-title":"Is intravenous lidocaine clinically effective in acute migraine?","volume":"11","author":"Reutens","year":"1991","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.clineuro.2025.109205_bib83","doi-asserted-by":"crossref","first-page":"157","DOI":"10.5694\/j.1326-5377.2000.tb125538.x","article-title":"Intravenous lignocaine infusions for severe chronic daily headache","volume":"172","author":"Hand","year":"2000","journal-title":"Med J. Aust."},{"issue":"10","key":"10.1016\/j.clineuro.2025.109205_bib84","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1468-2982.2003.00623.x","article-title":"Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse","volume":"23","author":"Williams","year":"2003","journal-title":"Cephalalgia Int J. Headache"},{"issue":"22","key":"10.1016\/j.clineuro.2025.109205_bib85","doi-asserted-by":"crossref","first-page":"9980","DOI":"10.1523\/JNEUROSCI.22-22-09980.2002","article-title":"The role of spinal neuroimmune activation in morphine tolerance\/hyperalgesia in neuropathic and sham-operated rats","volume":"22","author":"Raghavendra","year":"2002","journal-title":"J. Neurosci. J. Soc. Neurosci."},{"issue":"9","key":"10.1016\/j.clineuro.2025.109205_bib86","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/head.12655","article-title":"Glial attenuation with ibudilast in the treatment of medication overuse headache: a double-blind, randomized, placebo-controlled pilot trial of efficacy and safety","volume":"55","author":"Johnson","year":"2015","journal-title":"Headache"},{"key":"10.1016\/j.clineuro.2025.109205_bib87","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.871187","article-title":"Medical cannabis for the treatment of migraine in adults: a review of the evidence","volume":"13","author":"Okusanya","year":"2022","journal-title":"Front Neurol."},{"key":"10.1016\/j.clineuro.2025.109205_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2021.170651","article-title":"The involvement of orexin 1 and cannabinoid 1 receptors within the ventrolateral periaqueductal gray matter in the modulation of migraine-induced anxiety and social behavior deficits of rats","volume":"146","author":"Pourrahimi","year":"2021","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib89","first-page":"24","article-title":"Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin","volume":"37","author":"George","year":"1983","journal-title":"Biomed. Pharm. Biomedecine Pharm."},{"issue":"5","key":"10.1016\/j.clineuro.2025.109205_bib90","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2125.2011.03970.x","article-title":"Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials","volume":"72","author":"Lynch","year":"2011","journal-title":"Br. J. Clin. Pharm."},{"issue":"8","key":"10.1016\/j.clineuro.2025.109205_bib91","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s10194-012-0490-1","article-title":"Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial","volume":"13","author":"Pini","year":"2012","journal-title":"J. Headache Pain."},{"issue":"3","key":"10.1016\/j.clineuro.2025.109205_bib92","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1526-4610.1997.3703174.x","article-title":"Therapeutic blockade of greater occipital and supraorbital nerves in migraine patients","volume":"37","author":"Caputi","year":"1997","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.clineuro.2025.109205_bib93","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11916-003-0036-y","article-title":"The trigeminocervical complex and migraine: current concepts and synthesis","volume":"7","author":"Bartsch","year":"2003","journal-title":"Curr. Pain. Headache Rep."},{"issue":"10","key":"10.1016\/j.clineuro.2025.109205_bib94","first-page":"1479","article-title":"Occipital nerve blocks: effect of symptomatic medication: overuse and","volume":"49","author":"Tobin","year":"2009","journal-title":"Headache Type Fail. rate. Headache"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib95","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10072-021-05295-y","article-title":"Effects of greater occipital nerve block with local anesthetic and triamcinolone for treatment of medication overuse headache: an open-label, parallel, randomized, controlled clinical trial","volume":"43","author":"Arab","year":"2022","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib96","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1227\/01.NEU.0000192163.55428.62","article-title":"Peripheral neurostimulation for treatment of intractable occipital neuralgia","volume":"58","author":"Slavin","year":"2006","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.clineuro.2025.109205_bib97","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1468-2982.2007.01272.x","article-title":"Occipital Nerve Stimulation for Chronic Headache\u2014Long-Term Safety and Efficacy","volume":"27","author":"Schwedt","year":"2007","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib98","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2377-11-25","article-title":"Central modulation in cluster headache patients treated with occipital nerve stimulation: an FDG-PET study","volume":"11","author":"Magis","year":"2011","journal-title":"BMC Neurol."},{"issue":"3;5","key":"10.1016\/j.clineuro.2025.109205_bib99","doi-asserted-by":"crossref","first-page":"245","DOI":"10.36076\/ppj.2012\/15\/245","article-title":"Occipital Nerve Stimulation for ChronicMigraine: A Randomized Trial","volume":"3;15","author":"Serra","year":"2012","journal-title":"Pain. Physician"},{"issue":"6","key":"10.1016\/j.clineuro.2025.109205_bib100","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1468-2982.2009.02022.x","article-title":"Phenotype of patients responsive to occipital nerve stimulation for refractory head pain","volume":"30","author":"Paemeleire","year":"2010","journal-title":"Cephalalgia Int J. Headache"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib101","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1129-2377-14-86","article-title":"Neuromodulation of chronic headaches: position statement from the European Headache Federation","volume":"14","author":"Martelletti","year":"2013","journal-title":"J. Headache Pain."},{"issue":"8","key":"10.1016\/j.clineuro.2025.109205_bib102","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1007\/s00415-022-11059-1","article-title":"Outcomes of transcutaneous nerve stimulation for migraine headaches: a systematic review and meta-analysis","volume":"269","author":"Evans","year":"2022","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.clineuro.2025.109205_bib103","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/ijnp\/pyaa051","article-title":"evidence-based guidelines and secondary meta-analysis for the use of transcranial direct current stimulation in neurological and psychiatric disorders","volume":"24","author":"Fregni","year":"2021","journal-title":"Int J. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.clineuro.2025.109205_bib104","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1111\/head.13645","article-title":"Effects of non-invasive brain stimulation on headache intensity and frequency of headache attacks in patients with migraine: a systematic review and meta-analysis","volume":"59","author":"Feng","year":"2019","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clinph.2020.10.014","article-title":"Anodal transcranial direct current stimulation in CM and medication overuse headache: A pilot double-blind randomized sham-controlled trial","volume":"132","author":"De Icco","year":"2021","journal-title":"Clin. Neurophysiol."},{"issue":"11","key":"10.1016\/j.clineuro.2025.109205_bib106","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1177\/0333102420931050","article-title":"No efficacy of transcranial direct current stimulation on CM with medication overuse: A double blind, randomised clinical trial","volume":"40","author":"Grazzi","year":"2020","journal-title":"Cephalalgia Int J. Headache"},{"issue":"9","key":"10.1016\/j.clineuro.2025.109205_bib107","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1586\/14737175.7.9.1121","article-title":"Role of acupuncture in the treatment of migraine","volume":"7","author":"Endres","year":"2007","journal-title":"Expert Rev. Neurother."},{"issue":"1","key":"10.1016\/j.clineuro.2025.109205_bib108","first-page":"CD001218","article-title":"Acupuncture for migraine prophylaxis","volume":"21","author":"Linde","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"issue":"15","key":"10.1016\/j.clineuro.2025.109205_bib109","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1177\/0333102411420585","article-title":"Acupuncture versus topiramate in CM prophylaxis: a randomized clinical trial","volume":"31","author":"Yang","year":"2011","journal-title":"Cephalalgia Int J. Headache"},{"issue":"6","key":"10.1016\/j.clineuro.2025.109205_bib110","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1021\/bi052044w","article-title":"Identification and Pharmacological Characterization of Domains Involved in Binding of CGRP Receptor Antagonists to the Calcitonin-like Receptor","volume":"45","author":"Salvatore","year":"2006","journal-title":"Biochemistry"},{"issue":"24","key":"10.1016\/j.clineuro.2025.109205_bib111","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1111\/bph.14832","article-title":"Characterization of binding, functional activity, and contractile responses of the selective 5-HT 1F receptor agonist lasmiditan","volume":"176","author":"Rubio-Beltr\u00e1n","year":"2019","journal-title":"Br. J. Pharm."},{"issue":"2","key":"10.1016\/j.clineuro.2025.109205_bib112","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1811090","article-title":"Rimegepant, an Oral Calcitonin Gene\u2013Related Peptide Receptor Antagonist, for Migraine","volume":"381","author":"Lipton","year":"2019","journal-title":"N. Engl. J. Med"},{"issue":"19","key":"10.1016\/j.clineuro.2025.109205_bib113","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/jama.2019.16711","article-title":"Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial","volume":"322","author":"Lipton","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clineuro.2025.109205_bib114","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1474-4422(22)00517-8","article-title":"Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial","volume":"22","author":"Lipton","year":"2023","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.clineuro.2025.109205_bib115","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/brain\/awz134","article-title":"Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine","volume":"142","author":"Goadsby","year":"2019","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.clineuro.2025.109205_bib116","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMoa2035908","article-title":"Atogepant for the preventive treatment of migraine","volume":"385","author":"Ailani","year":"2021","journal-title":"N. Engl. J. Med"},{"issue":"8","key":"10.1016\/j.clineuro.2025.109205_bib117","first-page":"713","article-title":"Oral Rimegepant Safe, effective for migraine prevention","volume":"325","author":"Slomski","year":"2021","journal-title":"JAMA"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725004883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846725004883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T21:54:55Z","timestamp":1763675695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846725004883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":117,"alternative-id":["S0303846725004883"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109205","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication-overuse headache: Bridging therapies for detoxification","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2025.109205","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109205"}}